The Nerivio REN Wearable to Prevent and Treat Migraine - Designed with Teenagers in Mind

Migraine is a complex neurological disease that affects millions of teenagers in the US and worldwide [1]. But treatment options for adolescents are limited and some have never been evaluated for young adults or were not even developed to treat migraine. [2] This debilitating disease impacts day-to-day, and if not treated early and effectively it can even become chronic with age.

But it doesn't have to be this way.

Early diagnosis and effective therapy that is easy to follow can minimize the impact migraine has on teenagers now and can improve their chances of living a fulfilling life without the hurdle of uncontrolled migraine in the future. [3]

This is Nerivio, an FDA-cleared REN wearable developed with teens in mind.
This therapy prevents and treats migraine drug-free, and addresses our unmet need for early, safe, and effective treatment.

Nerivio easily wraps around the upper arm and is controlled with an app.
It uses non-painful stimulation to harness the natural power of the brain to control migraine pain and symptoms without drugs, needles, or disruption; even during class!

Nerivio. Complete migraine care, designed with teenagers in mind.

INDICATIONS FOR USE
Nerivio is indicated for acute and/or preventive treatment of migraine with or without aura in patients 12 years of age or older. It is a prescription use, self administered device for use in the home environment at the onset of migraine headache or aura for acute treatment, or every other day for preventive treatment.

CONTRAINDICATIONS
Nerivio should not be used by people with uncontrolled epilepsy, an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device. Such use could cause electric shock, electrical interference or serious injuries or medical conditions.

IMPORTANT SAFETY INFORMATION
Nerivio has not been evaluated in people with congestive heart failure (CHF), severe cardiac or cerebrovascular disease, for pregnancy, or those under the age of 12. Nerivio should only be applied on the upper arm over dry, healthy skin with normal physical sensation and without any metallic implants or in proximity to cancerous lesions.
Nerivio is available by prescription only. As with any therapy, side effects may occur and treatment results can vary from person to person. If you have any questions, consult your physician. For full user instructions and safety information, please refer to the Nerivio User Manual at www.nerivio.com.

REFERENCES
1. Kabbouche MA, Gilman DK. Management of migraine in adolescents. Neuropsychiatr Dis Treat. 2008;4(3):535-548. doi:10.2147/ndt.s495
2. Charles, J.A., Peterlin, B.L., Rapoport, A.M. et al. Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification. J Headache Pain 10, 227–233 (2009).
3. Freitag, F., & Schloemer, F. (2016, January). Recent developments in the treatment of migraine in children and adolescents. Journal of Headache & Pain Management, ISSN 2472-1913. DOI:10.4172/2472-1913.100009.